Study to find if high dose of radiotherapy in cervix cancer be completed in less time and its effects.

Hypo fractionated radiotherapy in carcinoma cervix- A phase II study. - nill

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/08/092387

Enrollment

Registered

2025-08-05

Start date

Unknown

Completion date

Unknown

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N889- Noninflammatory disorder of cervixuteri, unspecified Health Condition 2: N889- Noninflammatory disorder of cervixuteri, unspecified

Interventions

Intervention1: hypofractionated Radiation Thearpy: External beam radiation therapy of 42.6 Gy in 15 fractionation in 3 weeks followed by intracavitary Brachytherapy of 7 Gy x 3 fractions i,e weekly fo

Eligibility

Inclusion criteria

Inclusion criteria: Biopsy proven cancer cervix. Clinical Stage upto IIB with or without radiological IIIC1 KPS more than 70. Willing for participate.

Exclusion criteria

Exclusion criteria: Post op patients. Pregnant or lactating women. Metastasis.

Design outcomes

Primary

Measure	Time frame
assess response and acute toxicities, if anyTimepoint: assess response at 3 months and acute toxicities during Radiation therapy and uptil 6 months on 3 monthly follow up.	—

Secondary

Measure	Time frame
late toxicities, quality of life (QOL), Progression free survival (PFS) and overall survival (OS)Timepoint: at 6 months and 1 year.	—

Countries

India

Contacts

Public ContactDivyesh Kumar

Post Graduate Institute of Medical Education and Research

divyeshanand1@gmail.com7087441314

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026